An overview of the recommended therapeutic approach based on the different stages of HF is reported in the table below:
Many patients with HF are members of subpopulations or have comorbid conditions that either contribute to the development of their HF or make the management of their HF symptoms more difficult. These factors need to be considered in the management of such patients.
Many subgroups are underrepresented in most trials, and some present unique problems in HF management. These include women and men, racial minorities, and elderly patients.
Patients with left ventricular dysfunction frequently have associated cardiovascular and non-cardiovascular disorders, the course or treatment of which may exacerbate the